Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajeev S Samant

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Iscience|January 25, 2021
Hypoxia re-programs 2'-O-Me modifications on ribosomal RNABrandon J Metge, Sarah C Kammerud, Hawley C Pruitt, et al.
Cancer Research|March 18, 2022
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic ResistanceAmr R Elhamamsy, Brandon J Metge, Heba A Alsheikh, et al.
Oncology|March 11, 2010
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1Brandon J Metge, Suhu Liu, Adam I Riker, et al.
International Journal of Cancer|April 10, 2009
Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growthRebecca A Fillmore, Aparna Mitra, Yaguang Xi, et al.
Cancer Letters|April 16, 2014
Multi-targeted therapy of cancer by niclosamide: A new application for an old drugYonghe Li, Pui-Kai Li, Michael J Roberts, et al.
Cancer Letters|June 28, 2005
Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1)Rajeev S Samant, Michael T Debies, Douglas R Hurst, et al.
Journal of Cellular and Molecular Medicine|June 23, 2009
Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontinLalita A Shevde, Brandon J Metge, Aparna Mitra, et al.
Molecular Oncology|January 7, 2021
Merlin deficiency alters the redox management program in breast cancerMateus Mota, Brandon J Metge, Dominique C Hinshaw, et al.
Current Cancer Drug Targets|August 12, 2008
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stressDavid W Clark, Aparna Mitra, Rebecca A Fillmore, et al.
FEBS Letters|August 4, 2012
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistanceAndrew J Vincent, Suping Ren, Lillianne G Harris, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Iscience|January 25, 2021
Hypoxia re-programs 2'-O-Me modifications on ribosomal RNABrandon J Metge, Sarah C Kammerud, Hawley C Pruitt, et al.
Cancer Research|March 18, 2022
Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic ResistanceAmr R Elhamamsy, Brandon J Metge, Heba A Alsheikh, et al.
Oncology|March 11, 2010
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1Brandon J Metge, Suhu Liu, Adam I Riker, et al.
International Journal of Cancer|April 10, 2009
Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growthRebecca A Fillmore, Aparna Mitra, Yaguang Xi, et al.
Cancer Letters|April 16, 2014
Multi-targeted therapy of cancer by niclosamide: A new application for an old drugYonghe Li, Pui-Kai Li, Michael J Roberts, et al.
Cancer Letters|June 28, 2005
Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1)Rajeev S Samant, Michael T Debies, Douglas R Hurst, et al.
Journal of Cellular and Molecular Medicine|June 23, 2009
Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontinLalita A Shevde, Brandon J Metge, Aparna Mitra, et al.
Molecular Oncology|January 7, 2021
Merlin deficiency alters the redox management program in breast cancerMateus Mota, Brandon J Metge, Dominique C Hinshaw, et al.
Current Cancer Drug Targets|August 12, 2008
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stressDavid W Clark, Aparna Mitra, Rebecca A Fillmore, et al.
FEBS Letters|August 4, 2012
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistanceAndrew J Vincent, Suping Ren, Lillianne G Harris, et al.
Pageof 9